Recombinate Articles
Haloenzyme files US NDA for Enhanze SC
4 April 2005
Crucell and DSM sign deal with Mitsubishi
4 April 2005
Genentech and Ipsen add to existing accord
28 March 2005
Sweden's Biovitrum acquires Cambridge Biotechnology
28 March 2005
Pharming's C1 inhibitor CTA OKed in Canada
21 March 2005
Baxter's Advate shows good market acceptance
14 March 2005
BioPartners signs 10-year license accord with The Medical House
28 February 2005
Favorable Ph I results for TG's HIV vaccine
28 February 2005
Octoplus and Biolex collaborate on Locteron
28 February 2005
Pharmaxis begins UK Phase II for Bronchitol
21 February 2005
Shionogi's 3rd-qtr sees sales drop 2.9%
21 February 2005
Pharmaxis begins UK Phase II for Bronchitol
21 February 2005
ZymoGenetics Ph II trials of rhThrombin meet safety endpoint
21 February 2005
Pharming and Diosynth announce supply agreement
14 February 2005
Repligen and GE Healthcare expand Protein A supply deal
14 February 2005
Indian HIV vaccine program begins
14 February 2005
Novo Nordisk sees 4% profits rise for 2004
14 February 2005
Novartis shows off strong R&D pipeline at annual conference
31 January 2005
NIH initiates Ph I of HIV vacc developed with GenVec
31 January 2005
OctoPlus gains $23.8M in second financing
24 January 2005
MorphoSys acquires Biogenesis for $9.9M
24 January 2005
GlobeImmune/MycoLogics collaborate on antifungals
24 January 2005
ID Bio's plague vaccine goes into Ph I
17 January 2005
Tercica provides NDA update
17 January 2005
Pharming to acquire rest of ProBio
17 January 2005
Former Serono sales man pleads guilty to offering US kickbacks
10 January 2005
Insmed submits SomatoKine NDA
10 January 2005
Novo Nordisk updates on NovoSeven label expansion
10 January 2005
Japan stock market three weeks to January 3
10 January 2005
Indian govt backs rDNA approval streamlining
10 January 2005
Baxter's Advate gets expanded approval
10 January 2005
Pharmexa acquires patent estate from Vectron
10 January 2005
Myzozyme MAA lifts Genzyme
10 January 2005
FDA clears Amgen's Kepivance
20 December 2004
Bayer divests plasma business for $590M
20 December 2004
S-P's Peg-Intron launched in Japan
20 December 2004
Shreya Biotech to make recombinant human insulin from end-2005
22 November 2004
Ipsen/Octagen's OBI-1 to enter Ph II testing
22 November 2004
Richter Gedeon's nine-month profit grows 7%
22 November 2004
Positive results for Dyax/Genzyme's DX-88
22 November 2004
New markets for Dragon's EPO
22 November 2004
Richter Gedeon's nine-month profit grows 7%
22 November 2004
Xoma licenses BPI to Zephyr Sciences
22 November 2004
BioMimetic Pharma raises $25.7M
15 November 2004
VaxGen gains $877.5M US contract for anthrax vaccine
15 November 2004
California voters back stem cell research
15 November 2004
$7.4M NIH grant for Progenics and Cytogen
8 November 2004
Japan's Chugai posts nine-month results in line with forecasts
8 November 2004
BioPartners files for biosimilar IFN-alpha
1 November 2004
ZLB Behring donates $9.8 million of hemophilia drugs
1 November 2004
Expanded US use for Serono's Luveris
25 October 2004
Sandoz' Omnitrope OKed in Australia
11 October 2004
SBIR grant for Meridian in biodefence
11 October 2004
Novo Nordisk gains recombinant Factor XIII
11 October 2004
Biolex opens new cGMP biopharma manufacturing facility
4 October 2004
EC clears Medicines Co's Angiox
4 October 2004
Bayer and Schering-Plough form strategic pharmaceuticals alliance
20 September 2004
Insmed's anti-tumor agent enters clinic
20 September 2004
Novo Nordisk to appeal court's hGH patent rulings
13 September 2004
FDA defers decision on Sandoz' application for Omnitrope
13 September 2004
Pharming acquires PPL patent portfolio
30 August 2004
Apax Partners forms Aerovance via spin out of Bayer projects
30 August 2004
France to reimburse Baxter's Advate
30 August 2004
Baxter to market Halozyme's rHuPH20
23 August 2004
Crucell and DSM in MAb deal with GSK
23 August 2004
BioMarin sees 2nd-qtr loss rocket on Ascent acquisition
16 August 2004
Teva and Savient get favorable ruling on rHGH
16 August 2004
Merck & Co licenses Pierre Fabre's F50035
9 August 2004
Serono's 2nd-qtr net income jumps 26%
2 August 2004
Dragon gets approval for EPO in Ecuador
26 July 2004
US FDA plans Oncology Office and Program
26 July 2004
TKT's Hunter syndrome therapy on fast-track
26 July 2004
Serono infertility APIs to be made in Spain
19 July 2004
Genentech's 2nd-qtr sales rocket 42%
19 July 2004
Xolair being evaluated in peanut allergy
19 July 2004
First milestone in Crucell/DSM alliance
12 July 2004
Bayer donates Kogenate to hemophilia federation
5 July 2004
Stock Commentary - Tokyo
5 July 2004
Tokyo pharma stocks - week to june 28
5 July 2004
Amgen files palifermin BLA with FDA
5 July 2004
Ajinomoto sues Chugai over patents
14 June 2004
Stock Commentary - New York
7 June 2004
Baxter gets FDA warning on ADVATE promotion
7 June 2004
FDA OKs Serono's Gonal-f RFF Pen
31 May 2004
Wockhardt to export insulin to SE Asia
24 May 2004
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
